Animal Models of Demyelination of the Central Nervous System

  • A. Uccelli
Part of the Topics in Neuroscience book series (TOPNEURO)


Experimental autoimmune encephalomyelitis (EAE) is possibly the best animal model for studying autoimmune diseases and in particular demyelinating diseases of the central nervous system (CNS) such as multiple sclerosis (MS). Since the classic studies of Rivers et al. [1] in monkeys immunized with CNS homogenate, EAE has been an invaluable tool for dissecting mechanisms of the immune response against self-antigens within the CNS, as well for testing new therapies for the treatment of autoimmune diseases. An autoimmune response leading to EAE in susceptible species can be obtained by active immunization with CNS proteins or by passive transfer of T lymphocytes reactive against myelin antigens to syngeneic recipients. The role of T lymphocytes in EAE was first demonstrated by Paterson who succeeded in transferring disease by means of T cells from immunized animals [2]. Since then, many researchers have attempted to characterize the role of T cells in EAE. Over the years it became clear that activated CD4+ T cells mediate EAE upon recognition of the target antigen bound to class II molecules of the major histocompatibility complex (MHC) [3]. Encephalitogenic T cells can be retrieved from the blood of immunized as well as naive animals, supporting the concept that autoaggressive lymphocytes are part of the natural immune repertoire [4, 5].


Major Histocompatibility Complex Experimental Autoimmune Encephalomyelitis Myelin Basic Protein Experimental Allergic Encephalomyelitis Myelin Oligodendrocyte Glycoprotein 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Rivers TM, Sprunt DH, Berry GP (1933) Observations on the attempts to produce acute disseminated encephalomyelitis in monkeys. J Exp Med 58: 39–53PubMedCrossRefGoogle Scholar
  2. 2.
    Paterson PY (1960) Transfer of allergic encephalomyelitis in rats by means of lymph node cells. J Exp Med 111:119–135PubMedCrossRefGoogle Scholar
  3. 3.
    Zamvil SS, Steinman L (1990) The T lymphocyte in experimental allergic encephalomyelitis. Annu Rev Immunol 8: 579–621PubMedCrossRefGoogle Scholar
  4. 4.
    Schlusener HJ, Wekerle H (1985) Autoaggressive T-lymphocyte lines recognizing the encephalitogenic portion of myelin basic protein: in vitro selection from unprimed rat T-lymphocyte populations. J Immunol 135: 3128–3133Google Scholar
  5. 5.
    Genain CP, Lee-Parritz D, Nguyen MH et al. (1994) In healthy primate, circulating autoreactive T cells mediate autoimmune disease. J Clin Invest 94: 1339–1345PubMedCrossRefGoogle Scholar
  6. 6.
    Ben-Nun A, Wekerle H, Cohen IR (1981) The rapid isolation of clonable antigen specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur J Immunol 11: 195–199PubMedCrossRefGoogle Scholar
  7. 7.
    Yamamura T, Namikawa T, Endoh M et al. (1986) Passive transfer of experimental allergic encephalomyelitis induced by proteolipid apoprotein. J Neurol Sci 76: 269–275PubMedCrossRefGoogle Scholar
  8. 8.
    Linington C, Berger T, Perry L et al. (1993) T cells specific for the myelin oligodendrocyte glycoprotein (MOG) mediate an unusual autoimmune inflammatory response in the central nervous system. Eur J Immunol 23: 1364–1372PubMedCrossRefGoogle Scholar
  9. 9.
    Linington C, Bradl M, Lassmann H et al. (1988) Augmentation of demyelination in rat acute allergie encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am J Pathol 130: 443–454PubMedGoogle Scholar
  10. 10.
    Massacesi L, Vergelli M, Zehetbauer B et al. (1993) Induction of experimental autoimmune encephalomyelitis in rats and immune response to myelin basic protein in lipid bound form. J Neurol Sci 119: 91–98PubMedCrossRefGoogle Scholar
  11. 11.
    Kojima K, Berger T, Lassmann H et al. (1994) Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the Sl00β molecule, a calcium binding protein of astroglia. J Exp Med 180: 817–829PubMedCrossRefGoogle Scholar
  12. 12.
    Raine CS (1997) The lesion in multiple sclerosis and chronic relapsing experimental allergic encephalomyelitis: A structural comparison. In: Raine CS, McFarland HF, Tourtellotte WW (eds) Multiple sclerosis: clinical and pathogenetic basis. Chapman and Hall, London, pp 242–286Google Scholar
  13. 13.
    Olitsky PK, Yager RH (1949) Experimental disseminated encephalomyelitis in mice. J Exp Med 90: 213–223PubMedCrossRefGoogle Scholar
  14. 14.
    Lisak RP, Zweiman B, Kies MW, Driscoll B (1975) Experimental allergic encephalomyelitis in resistant and susceptible guinea pigs: in vivo and in vitro correlates. J Immunol 114: 546–549PubMedGoogle Scholar
  15. 15.
    Brown AM, McFarlin DE (1981) Relapsing experimental allergic encephalomyelitis in the SJL/J mouse. Lab Invest 45: 278–284PubMedGoogle Scholar
  16. 16.
    Mokhtarian F, McFarlin DE, Raine CS (1984) Adoptive transfer of myelin basic protein-sensitized T-cells produces chronic relapsing demyelinating disease in mice. Nature 309: 356–358PubMedCrossRefGoogle Scholar
  17. 17.
    Sakai K, Sinha A A, Mitchell DJ et al. (1988) Involvement of distinct murine T-cell receptors in the autoimmune encephalitogenic response to nested epitopes of myelin basic protein. Proc Natl Acad Sci USA 85: 8608–8612PubMedCrossRefGoogle Scholar
  18. 18.
    Burns FR, Li RX, Shen L et al. (1989) Both rat and mouse T-cell receptors specific for the encephalitogenic determinant of myelin basic protein use similar Vα and Vβ chain genes even though the major histocompatibility complex and encephalitogenic determinants being recognized are different. J Exp Med 169: 27–39PubMedCrossRefGoogle Scholar
  19. 19.
    Lassmann H, Brunner C, Bradl M, Linington C (1988) Experimental allergic encephalomyelitis: the balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions. Acta Neuropathol 75: 566–576PubMedCrossRefGoogle Scholar
  20. 20.
    Vandenbark AA, Offner H, Reshef T et al. (1985) Specificity of T lymphocyte lines for peptides of myelin basic protein. J Immunol 139: 229–233Google Scholar
  21. 21.
    Kim G, Tanuma N, Kojima T et al. (1998) CDR3 size spectratyping and sequencing of spectratype-derived TCR of spinal cord T cells in autoimmune encephalomyelitis. J Immunol 160: 509–513PubMedGoogle Scholar
  22. 22.
    Zaller DM, Osman G, Kanagawa O, Hood L (1990) Prevention and treatment of murine experimental allergic encephalomyelitis with T-cell receptor Vβ-specific antibodies. J Exp Med 171: 1943–1955PubMedCrossRefGoogle Scholar
  23. 23.
    Howell MD, Winters ST, Olee T et al. (1989) Vaccination against experimental encephalomyelitis with T cell receptor peptides. Science 246: 668–670PubMedCrossRefGoogle Scholar
  24. 24.
    Lehmann PV, Forsthuber T, Miler A, Sercarz EE (1992) Spreading of T cell autoimmunity to cryptic determinants of an autoantigen. Nature 358: 155–157PubMedCrossRefGoogle Scholar
  25. 25.
    Offner H, Buenafe AC, Vainiene M et al. (1993) Where, when and how to detect biased expression of disease relevant Vβ genes in rats with experimental autoimmune encephalomyelitis. J Immunol 151: 506–517PubMedGoogle Scholar
  26. 26.
    Bauer J, Wekerle H, Lassmann H (1995) Apoptosis in brain-specific autoimmune disease. Curr Opin Immunol 7: 839–843PubMedCrossRefGoogle Scholar
  27. 27.
    Baker D, O’Neill JK, Gschmeissner SE et al. (1990) Induction of chronic relapsing experimental allergic encephalomyelitis in Biozzi mice. J Neuroimmunol 28: 261–270PubMedCrossRefGoogle Scholar
  28. 28.
    Amor S, Groome N, Linington C et al. (1994) Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J Immunol 153: 4349–4356PubMedGoogle Scholar
  29. 29.
    Lorentzen JC, Issazadeh S, Storch M et al. (1995) Protracted relapsing and demyelinating experimental autoimmune encephalomyelitis in DA rats immunized with syngeneic spinal cord and incomplete Freund’s adjuvant. J Neuroimmunol 63: 193–205PubMedCrossRefGoogle Scholar
  30. 30.
    Greer JM, Sobel RA, Sette A et al. (1996) Immunogenic and encephalitogenic epitope clusters of myelin proteolipid protein. J Immunol 156: 371–379PubMedGoogle Scholar
  31. 31.
    Targoni OS, Lehmann PV (1998) Endogenous myelin basic protein inactivates the high avidity T cell repertoire. J Exp Med 187: 2055–2063PubMedCrossRefGoogle Scholar
  32. 32.
    Sundvall M, Jirholt J, Yang HT et al. (1995) Identification of murine loci associated with susceptibility to chronic experimental autoimmune encephalomyelitis. Nat Genet 10: 313–317PubMedCrossRefGoogle Scholar
  33. 33.
    Weissert R, Wallstrom E, Storch MK et al. (1998) MHC haplotype-dependent regulation of MOG-induced EAE in rats. J Clin Invest 102: 1265–1273PubMedCrossRefGoogle Scholar
  34. 34.
    Goverman J, Woods A, Larson L et al. (1993) Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 72: 551–560PubMedCrossRefGoogle Scholar
  35. 35.
    Lafaille J, Nagashima K, Katsuki M, Tonegawa S (1994) High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell 78: 399–408PubMedCrossRefGoogle Scholar
  36. 36.
    Kumar V, Sercarz EE (1993) The involvement of T cell receptor peptide-specific regulatory CD4+ T cells in recovery from antigen induced autoimmune disease. J Exp Med 178: 909–916PubMedCrossRefGoogle Scholar
  37. 37.
    Jiang H, Zhang SI, Pernis B (1992) Role of CD8+ T cells in murine experimental allergic encephalomyelitis. Science 256: 1213–1215PubMedCrossRefGoogle Scholar
  38. 38.
    Kozovska MF, Yamamura T, Tabira T (1996) T-T cell interaction between CD4-CD8-regulatory T cells and T cell clones presenting TCR peptide. Its implications for TCR vaccination against experimental autoimmune encephalomyelitis. J Immunol 157: 1781–1790PubMedGoogle Scholar
  39. 39.
    Huitinga I, Van Rooijen N, De Groot CJA et al. (1990) Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J Exp Med 172: 1025–1033PubMedCrossRefGoogle Scholar
  40. 40.
    Wolf SD, Dittel BN, Hardardottir F, Janaway CA (1996) Experimental autoimmune encephalomyelitis induction in genetically B-cell deficient mice. J Exp Med 184: 2271–2278PubMedCrossRefGoogle Scholar
  41. 41.
    Kobayashi Y, Kaway K, Ito K et al. (1997) Aggravation of murine experimental allergic encephalomyelitis by administration of T-cell receptor γδ-specific antibodies. J Neuroimmunol 73: 169–174PubMedCrossRefGoogle Scholar
  42. 42.
    Zhang BN, Yamamura T, Kondo T et al. (1997) Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J Exp Med 186: 1677–1687PubMedCrossRefGoogle Scholar
  43. 43.
    Naparstek Y, Ben-Nun A, Holoshitz J et al. (1983) T lymphocyte line producing or vaccinating against autoimmune encephalomyelitis (EAE). Functional activation induces peanut agglutinin receptors and accumulation in the brain and thymus of line cells. Eur J Immunol 13: 418–423PubMedCrossRefGoogle Scholar
  44. 44.
    Ufret-Vincenty RL, Quigley L, Tresser N et al. (1998) In vivo survival of viral antigen-specific T cells that induce experimental autoimmune encephalomyelitis. J Exp Med 188: 1725–1738PubMedCrossRefGoogle Scholar
  45. 45.
    Brocke S, Gaur A, Piercy C et al. (1993) Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen. Nature 365: 642–644PubMedCrossRefGoogle Scholar
  46. 46.
    Padovan E, Giachino C, Cella M et al. (1995) Normal T lymphocytes can express two different T cell receptor β chains: implications for the mechanism of allelic exclusion. J Exp Med 181: 1587–1591PubMedCrossRefGoogle Scholar
  47. 47.
    Cannella B, Cross AH, Raine CS (1990) Upregulation and coexpression of adhesion molecules correlates with experimental autoimmune demyelination in the central nervous system. J Exp Med 172: 1521–1524PubMedCrossRefGoogle Scholar
  48. 48.
    Myers KJ, Dougherty JP, Ron Y (1993) In vivo antigen presentation by both brain parenchymal cells and hematopoietically derived cells during the induction of experimental autoimmune encephalomyelitis. J Immunol 15: 2252–2260Google Scholar
  49. 49.
    Traugott U, McFarlin DE, Raine CS (1986) Immunopathology of the lesion in chronic relapsing experimental autoimmune encephalomyelitis in the mouse. Cell Immunol 99: 394–410CrossRefGoogle Scholar
  50. 50.
    Olsson T (1994) Role of cytokines in multiple sclerosis and experimental autoimmune encephalomyelitis. Eur J Neurol 1: 7–19CrossRefGoogle Scholar
  51. 51.
    Selmaj KW, Raine CS (1988) Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 23: 339–346PubMedCrossRefGoogle Scholar
  52. 52.
    Compston DA, Scolding NJ (1991) Immune-mediated oligodendrocyte injury. Ann N Y Acad Sci 633: 196–204PubMedCrossRefGoogle Scholar
  53. 53.
    Conboy YM, DeKruyff R, Tate KM et al. (1997) Novel genetic regulation of T helper 1 (Th1)/Th2 cytokine production and encephalitogenicity in inbred mouse strains. J Exp Med 185: 439–451PubMedCrossRefGoogle Scholar
  54. 54.
    Baron JL, Madri JA, Ruddle NH et al. (1993) Surface expression of α4 integrin by CD4 T cells is required for their entry into brain parenchyma. J Exp Med 177: 57–68PubMedCrossRefGoogle Scholar
  55. 55.
    Beraud E, Balzano C, Zamora AJ et al. (1993) Pathogenic and non-pathogenic T lymphocytes specific for the encephalitogenic epitope of myelin basic protein: functional characteristics and vaccination properties. J Neuroimmunol 47: 41–54PubMedCrossRefGoogle Scholar
  56. 56.
    Sun D, Wekerle H (1986) Ia-restricted encephalitogenic T lymphocytes mediating EAE lyse autoantigen-presenting astrocytes. Nature 320: 70–72PubMedCrossRefGoogle Scholar
  57. 57.
    Jeong MC, Itzikson A, Uccelli A et al. (1998) Differential display analysis of encephalitogenic mRNA. Int Immunol (in press)Google Scholar
  58. 58.
    Mustafa M, Vingsbo C, Olsson T et al. (1993) The major histocompatibility complex influences myelin basic protein 68–86-induced T-cell cytokine profile and experimental autoimmune encephalomyelitis. Eur J Immunol 23: 3089–3095PubMedCrossRefGoogle Scholar
  59. 59.
    Forsthuber T, Yip HC, Lehmann PV (1996) Induction of TH1 and TH2 immunity in neonatal mice. Science 271: 1728–1730PubMedCrossRefGoogle Scholar
  60. 60.
    Krakowski ML, Owens T (1997) The central nervous system environment controls effector CD4+ T cell cytokine profile in experimental allergic encephalomyelitis. Eur J Immunol 27: 2840–2847PubMedCrossRefGoogle Scholar
  61. 61.
    Aloisi F, Ria F, Penna G, Adorini L (1998) Microglia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 cell activation. J Immunol 160: 4671–4680PubMedGoogle Scholar
  62. 62.
    Falcone M, Bloom BR (1997) A T helper cell 2 (Th2) immune response against non-self antigens modifies the cytokine profile of autoimmune T cells and protects against experimental allergic encephalomyelitis. J Exp Med 185: 901–907PubMedCrossRefGoogle Scholar
  63. 63.
    Kuchroo VK, Das MP, Brown JA et al. (1995) B7–1 and B7–2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80: 707–718PubMedCrossRefGoogle Scholar
  64. 64.
    Nicholson LB, Greer JM, Sobel RA et al. (1995) An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity 3: 397–405PubMedCrossRefGoogle Scholar
  65. 65.
    Weiner HL (1997) Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol Today 18: 335–343PubMedCrossRefGoogle Scholar
  66. 66.
    Racke MK, Bonomo A, Scott DE et al. (1994) Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med 180: 1961–1966PubMedCrossRefGoogle Scholar
  67. 67.
    Ruddle NH, Bergman CM, McGrath KM et al. (1990) An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J Exp Med 172: 1193–1200PubMedCrossRefGoogle Scholar
  68. 68.
    Leonard JP, Waldburger KE, Goldman SJ (1995) Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J Exp Med 181: 381–386PubMedCrossRefGoogle Scholar
  69. 69.
    Genain CP, Abel K, Belmar N et al. (1996) Late complications of immune deviation therapy in a nonhuman primate. Science 274: 2054–2057PubMedCrossRefGoogle Scholar
  70. 70.
    Taupin V, Renno T, Bourbonniere L et al. (1997) Increased severity of experimental autoimmune encephalomyelitis, chronic macrophage/microglial reactivity, and demyelination in transgenic mice producing tumor necrosis factor-alpha in the central nervous system. Eur J Immunol 27: 905–913PubMedCrossRefGoogle Scholar
  71. 71.
    Frei K, Eugster HP, Bopst M et al. (1997) Tumor necrosis factor alpha and lympho-toxin alpha are not required for induction of acute experimental autoimmune encephalomyelitis. J Exp Med 185: 2177–2182PubMedCrossRefGoogle Scholar
  72. 72.
    Liu J, Marino MW, Wong G et al. (1998) TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat Med 4: 78–83PubMedCrossRefGoogle Scholar
  73. 73.
    Ferber IA, Brocke S, Taylor-Edwards C et al. (1996) Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J Immunol 156: 5–7PubMedGoogle Scholar
  74. 74.
    Bettelli E, Das MP, Howard ED et al. (1998) IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J Immunol 161: 3299–3306PubMedGoogle Scholar
  75. 75.
    Sahrbacher UC, Lechner F, Eugster HP et al. (1998) Mice with an inactivation of the inducible nitric oxide synthase gene are susceptible to experimental autoimmune encephalomyelitis. Eur J Immunol 28: 1332–1338PubMedCrossRefGoogle Scholar
  76. 76.
    Malipiero U, Frei K, Spanaus KS et al. (1997) Myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis is chronic/relapsing in perforin knockout mice, but monophasic in Fas- and Fas ligand-deficient lpr and gld mice. Eur J Immunol 27: 3151–3160PubMedCrossRefGoogle Scholar
  77. 77.
    Bontrop RE, Otting N, Slierendregt BL, Lanchbury JS (1995) Evolution of major histocompatibility complex polymorphisms and T-cell receptor diversity in primates. Immunol Rev 143: 43–62CrossRefGoogle Scholar
  78. 78.
    Massacesi L, Genain CP, Lee-Parritz D et al. (1995) Chronic relapsing experimental autoimmune encephalomyelitis in new world primates. Ann Neurol 37: 519–530PubMedCrossRefGoogle Scholar
  79. 79.
    Uccelli A, Oksenberg JR, Jeong M et al. (1997) Characterization of the TCRB chain repertoire in the New World monkey Callithrix jacchus. J Immunol 158: 1201–1207PubMedGoogle Scholar
  80. 80.
    Antunes SG, de Groot NG, Brok H et al. (1998) The common marmoset: a new world primate species with limited MHC class II variability. Proc Natl Acad Sci USA 95: 11745–11750PubMedCrossRefGoogle Scholar
  81. 81.
    Genain CP, Nguyen MH, Letvin NL et al. (1995) Antibody facilitation of multiple sclerosis-like lesions in a non-human primate. J Clin Invest 96: 2966–2974PubMedCrossRefGoogle Scholar
  82. 82.
    ’t Hart BA, Bauer J, Muller HJ et al. (1998) Histopathological characterization of magnetic resonance imaging-detectable brain white matter lesions in a primate model of multiple sclerosis: a correlative study in the experimental autoimmune encephalomyelitis model in common marmosets (Callithrix jacchus). Am J Pathol 153: 649–663PubMedCrossRefGoogle Scholar
  83. 83.
    Laman JD, van Meurs M, Schellekens MM et al. (1998) Expression of accessory molecules and cytokines in acute EAE in marmoset monkeys (Callithrix jacchus). J Neuroimmunol 86: 30–45PubMedCrossRefGoogle Scholar
  84. 84.
    Genain CP, Roberts T, Davis R et al. (1995) Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor. Proc Natl Acad Sci USA 92: 3601–3605PubMedCrossRefGoogle Scholar
  85. 85.
    Shaw CM, Alvord EC, Hruby S (1988) Chronic remitting-relapsing experimental allergic encephalomyelitis induced in monkeys with homologous myelin basic protein. Ann Neurol 24: 738–748PubMedCrossRefGoogle Scholar
  86. 86.
    Massacesi L, Joshi N, Lee-Parritz D et al. (1992) Experimental allergic encephalomyelitis in cynomolgus monkeys. Quantitation of T cell responses in peripheral blood. J Clin Invest 90: 399–404PubMedCrossRefGoogle Scholar
  87. 87.
    Slierendregt BL, Hall M,’t Hart B et al. (1995) Identification of an MHC-DPB1 allele involved in susceptibility to experimental autoimmune encephalomyelitis in rhesus macaques. Int Immunol 7: 1671–1679PubMedCrossRefGoogle Scholar
  88. 88.
    Van Lambalgen R, Jonker M (1987) Experimental allergic encephalomyelitis in the rhesus monkey. Treatment of EAE with anti-T lymphocyte subset monoclonal anti-bodies. Clin Exp Immunol 67: 305–312Google Scholar
  89. 89.
    Meinl E, Hoch RM, Dornmair K et al. (1997) Differential encephalitogenic potential of myelin basic protein-specific T cell isolated from normal rhesus macaques. Am J Pathol 150: 445–453PubMedGoogle Scholar
  90. 90.
    Theiler M (1934) Spontaneous encephalomyelitis of mice: a new virus disease. Science 80: 122PubMedCrossRefGoogle Scholar
  91. 91.
    Rodriguez M, Pavelko KD, Njenga MK et al. (1996) The balance between persistent virus infection and immune cells determines demyelination. J Immunol 157: 5699–5709PubMedGoogle Scholar
  92. 92.
    Lin X, Pease LR, Murray PD, Rodriguez M (1998) Theiler’s virus infection of genetically susceptible mice induces central nervous system-infiltrating CTLs with no apparent viral or major myelin antigenic specificity. J Immunol 160: 5661–5668PubMedGoogle Scholar
  93. 93.
    Lin X, Pease LR, Rodriguez M (1997) Differential generation of class I H-2D- versus H-2K-restricted cytotoxicity against a demyelinating virus following central nervous system infection. Eur J Immunol 27: 963–970PubMedCrossRefGoogle Scholar
  94. 94.
    Miller SD, Vanderlugt CL, Begolka WS et al. (1997) Persistent infection with Theiler’s virus leads to CNS autoimmunity via epitope spreading. Nat Med 3: 1133–1136PubMedCrossRefGoogle Scholar
  95. 95.
    Tuohy VK, Lu Z, Sobel RA, Laursen RA, Lees MB (1989) Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. J Immunol 142: 1523–1527PubMedGoogle Scholar
  96. 96.
    Mendel I, Kerlero de Rosbo N, Ben-Nun A (1995) A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells. Eur J Immunol 215: 1951–1959CrossRefGoogle Scholar
  97. 97.
    Kerlero de Rosbo N, Mendel I, Ben-Nun A (1995) Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes. Eur J Immunol 25: 985–993PubMedCrossRefGoogle Scholar
  98. 98.
    Hoffman PM, Gaston DD, Spitler LE (1973) Comparison of experimental allergic encephalomyelitis induced with spinal cord, basic protein, and synthetic encephalito-genetic peptide. Clin Immunol Immunopathol 1: 364–371PubMedCrossRefGoogle Scholar
  99. 99.
    Freund, Lipton MM, Morrison LR (1950) Arch Patol 50: 108Google Scholar

Copyright information

© Springer-Verlag Italia 1999

Authors and Affiliations

  • A. Uccelli
    • 1
  1. 1.Neuroimmunology Unit, Department of Neurological Sciences and NeurorehabilitationUniversity of GenoaItaly

Personalised recommendations